Avidity Biosciences, Inc. — Director's Dealing 2021

Jan 25, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Avidity Biosciences, Inc. (RNA)
CIK: 0001599901
Period of Report: 2021-01-21

Reporting Person: Flanagan W. Michael (Chief Technical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-21	Stock Option (Right to Buy)	$26.75	A	150000	Acquired	2031-01-20	Common Stock (150000)	Direct

Footnotes

F1: 25% of the shares subject to the option shall vest on January 21, 2022, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.